Results 241 to 250 of about 2,484,237 (280)
Some of the next articles are maybe not open access.

Polypharmacology of dopamine receptor ligands

Progress in Neurobiology, 2016
Most neurological diseases have a multifactorial nature and the number of molecular mechanisms discovered as underpinning these diseases is continuously evolving. The old concept of developing selective agents for a single target does not fit with the medical need of most neurological diseases.
S. Butini   +10 more
openaire   +7 more sources

Peripheral Dopamine Receptors

American Journal of Hypertension, 1990
Since 1979 when two subtypes of peripheral dopamine receptors (DA1 and DA2) were first proposed, much progress has been made to confirm such a view. Cumulative experience with the dog in vivo models suggests that the potency order: fenoldopam greater than dopamine greater than dipropyl dopamine greater than apomorphine characterizes the DA1 receptor ...
openaire   +3 more sources

D1 dopamine receptors

2001
Publisher Summary This chapter provides an overview of the role of the Dl-like dopamine receptors in nervous system function. The goal is to provide a broader, integrated overview that relates the structure and function of these interesting receptors to how the D1 receptors may interact with human neurological and psychiatric diseases. The peripheral
Cindy P. Lawler   +4 more
openaire   +3 more sources

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

American Journal of Psychiatry, 2001
OBJECTIVE The role of dopamine in the addictive process (loss of control and compulsive drug intake) is poorly understood. A consistent finding in drug-addicted subjects is a lower level of dopamine D2 receptors.
N. Volkow   +12 more
semanticscholar   +1 more source

Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine

European Journal of Pharmacology, 1988
Electrically stimulated release of [3H]dopamine [( 3H]DA) in slices of rat striatum was dose dependently inhibited by apomorphine (67% maximal inhibition) with an EC50 of 17 nM. DA receptor inactivation with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ; 0.5 and 2 mg/kg) dose dependently shifted the ED50 for apomorphine to the right and reduced ...
Hideyasu Yokoo   +2 more
openaire   +3 more sources

The Dopamine Receptors

1997
Table of Contents Preface Historical Overview: Introduction to the Dopamine Receptors Philip Seeman Gene and Promoter Structures of the Dopamine Receptors Ursula M. D'Souza Structural Basis of Dopamine Receptor Activation Irina S. Moreira, Lei Shi, Zachary Freyberg, Spencer S. Eriksen, Harel Weinstein, and Johnathan A. Javitch Dopamine Receptor Subtype-
openaire   +2 more sources

Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors

Neuropharmacology, 1986
The purpose of this study was to examine whether caffeine stimulates dopamine (DA) receptors. The effects of caffeine on the binding of [3H]spiperone to membranes from the striatum, accumulation of L-DOPA in the striatum in mice receiving gamma-butyrolactone, and regional levels of 3,4-dihydroxyphenylacetic acid in the brain of the rat were ...
H. Watanabe, H. Uramoto
openaire   +3 more sources

Dopamine D2 receptors in discrimination learning and spine enlargement

Nature, 2020
Y. Iino   +6 more
semanticscholar   +1 more source

Dopamine and dopamine receptor agonists in cardiovascular therapy

Critical Care Medicine, 1990
Dopamine (DA)--previously regarded simply as the precursor of norepinephrine--is now known to have its own unique effects on cardiovascular regulation which are mediated, in part, by activating specific DA receptors. DA has long been used in the treatment of shock and heart failure.
Michael B. Murphy, William J. Elliott
openaire   +3 more sources

Dopamine Receptor Oligomerization

2009
Each dopamine (DA) receptor subtype physically interacts with its own kind (homomers) or other receptors (heteromers) in the plasma membrane of neurons in the basal ganglia to form dimeric or high-order receptor oligomers, termed dimeric or high-order receptor mosaics (RMs).
Fuxe K   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy